Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CRVS compared with EWTX: revenue, margins and what each company keeps, and the suppliers and customers both name
CRVS
Corvus Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
EWTX
Edgewise Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
CRVS
Corvus Pharmaceuticals, Inc.
vs
EWTX
Edgewise Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
CRVS, solid
EWTX, dashed
Supply-chain overlap
Revenue flow
CRVS: latest quarter not drawable. EWTX: latest quarter not drawable.
Method
›
CRVS
Corvus Pharmaceuticals, Inc.
Change
9.70
· pre 9.76
· delayed
Mkt cap
$816.0M
EWTX
Edgewise Therapeutics, Inc.
Change
38.13
· pre 38.14
· delayed
Pre-market
Nov 2 '26
delayed
Mkt cap
$4.2B
vs
Compare
Pre-market
Nov 2 '26
delayed
CRVS
Corvus Pharmaceuticals, Inc.
vs
EWTX
Edgewise Therapeutics, Inc.
9.70
pre 9.76
delayed
Price
38.13
pre 38.14
delayed
$816.0M
Mkt cap
$4.2B
Change
Change
CRVS
9.70
vs
EWTX
38.13
Pre-market
Nov 2 '26
delayed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only CRVS
1
—
Angel Pharmaceuticals
unlisted
supplier
Shared
0
No shared counterparties.
Only EWTX
2
—
Leerink
unlisted
supplier
—
Silicon Valley Bank (SVB)
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR